miR-30c-2-3p Regulates METTL14 Expression and Inhibits Cell Migration in Breast Cancer
Zeliha Emrence, Seyma Punar, Vahideh Zarerajabi, Sena Uslu, Neslihan Abaci, Sema Sirma Ekmekci · 2026
Read miR-30c-2-3p Regulates METTL14 Expression and Inhibits Cell Migration in Breast Cancer by Zeliha Emrence, Seyma Punar, Vahideh Zarerajabi, Sena Uslu, Neslihan Abaci, Sema Sirma Ekmekci (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13297355.txt.
Description
Zeliha Emrence and colleagues test a tiny RNA that reins in a gene-editing enzyme inside breast cells, in a 2026 laboratory study. The enzyme, METTL14, places chemical marks on RNA that can help cancers grow. The team added extra copies of the small RNA, miR-30c-2-3p, to normal breast cells and to breast cancer cells.
Both cell types then made less METTL14, in message and in protein, within two days. Overall RNA marking fell as well, most sharply in the normal cells. In scratch tests, treated cells also crawled far more slowly, with closure cut by roughly a third to two thirds. The small RNA acts like a tumour brake here, and the authors name it a marker and drug target candidate.
Catalog record
| CREATOR | Zeliha Emrence, Seyma Punar, Vahideh Zarerajabi, Sena Uslu, Neslihan Abaci, Sema Sirma Ekmekci |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |